Santhera Pharmaceuticals Holding announced the closing of the first tranche of its financing arrangement with a fund managed by Highbridge Capital Management. The team was led by partner Matthias Courvoisier (Capital Markets) and senior associate
Tags :Yves Mauchle
The team consisted of partner Matthias Courvoisier, senior associate Yves Mauchle and trainee Jan Lusti
Zur Rose Group via its subsidiary Zur Rose Finance successfully completed the placement of senior unsecured bonds due 2025 guaranteed by the Company and convertible into registered shares of the Company.